🇫🇷 France Country × Condition
breast cancer female Clinical Trials in France
Active clinical trials for breast cancer female with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇫🇷 France
Active Trials in France (3)
NCT06552091
Recruiting
Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Adjuvant Hormone Therapy
Enrollment
76 pts
Country
🇫🇷 France
Institut de Cancérologie de Lorrain...
View Trial → NCT05116449
Recruiting
Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein)
Enrollment
310 pts
Country
🇫🇷 France
GCS Ramsay Santé pour l'Enseignemen...
View Trial → NCT04133077
Recruiting
Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer
Enrollment
85 pts
Country
🇫🇷 France
Centre Jean Perrin
View Trial → Frequently Asked Questions
How many breast cancer female clinical trials are active in France?
There are currently 3 active clinical trials for breast cancer female with sites in France, of which 3 are actively recruiting patients.
How can I join a breast cancer female clinical trial in France?
To join a breast cancer female clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer female trials in France?
Active breast cancer female trials in France span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology